Dashboard-Driven Accelerated Infliximab Induction Dosing Increases Infliximab Durability and Reduces Immunogenicity.
Sign Up to like & getrecommendations! Published in 2022 at "Inflammatory bowel diseases"
DOI: 10.1093/ibd/izab285
Abstract: BACKGROUND AND AIMS Accelerated infliximab (IFX) induction is often based on clinical parameters as opposed to pharmacokinetics (PK). We aimed to investigate the impact of dashboard-guided optimized induction dosing on IFX durability and immunogenicity in… read more here.
Keywords: accelerated infliximab; induction dosing; durability; immunogenicity ... See more keywords
Colonic Dilatation Complicating Acute Severe Ulcerative Colitis Managed Successfully with Accelerated Infliximab Dosing
Sign Up to like & getrecommendations! Published in 2023 at "Case Reports in Gastroenterology"
DOI: 10.1159/000529152
Abstract: Abstract Lately, emerging data suggest an association between the development of inflammatory bowel disease and anti-interleukin-17 therapy. Megacolon is a life-threatening complication of acute severe ulcerative colitis (ASUC), but its treatment has not yet been… read more here.
Keywords: accelerated infliximab; colonic dilatation; severe ulcerative; ulcerative colitis ... See more keywords
Evaluation of the safety and satisfaction of rheumatic patients with accelerated infliximab infusion
Sign Up to like & getrecommendations! Published in 2018 at "Advances in Rheumatology"
DOI: 10.1186/s42358-018-0016-x
Abstract: IntroductionInfliximab infusion generally occurs in 2–4 h. Recent studies have suggested the possibility of accelerated infusion (1 h) of this drug.ObjectiveTo evaluate the safety of accelerated infliximab infusion in patients with rheumatic diseases. In addition, patient satisfaction… read more here.
Keywords: satisfaction; rheumatic patients; infusion; safety ... See more keywords